BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang G, Ma W, Li Y, Jiang Y, Ma G, Zhang X, Meng L, Du J. Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study. European Journal of Cardio-Thoracic Surgery 2018;54:237-45. [DOI: 10.1093/ejcts/ezy022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Shi L, Li J, Wang H, Yang H. The roles of TG-interacting factor in cadmium exposure-promoted invasion and migration of lung cancer cells. Toxicology in Vitro 2019;61:104630. [DOI: 10.1016/j.tiv.2019.104630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hirji SA, D'Amico TA. Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma. J Thorac Dis 2018;10:S3286-9. [PMID: 30370139 DOI: 10.21037/jtd.2018.08.116] [Reference Citation Analysis]
3 Gkogkou P, Peponi E, Ntaskagiannis D, Murray S, Demou A, Sainis I, Ioakeim E, Briasoulis E, Tsekeris P. E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy. In Vivo 2020;34:453-9. [PMID: 31882513 DOI: 10.21873/invivo.11795] [Reference Citation Analysis]
4 Qin Q, Li X, Liang X, Zeng L, Wang J, Sun L, Zhong D. Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR-mutant non-small cell lung cancer. Thorac Cancer 2021;12:1708-15. [PMID: 33943009 DOI: 10.1111/1759-7714.13906] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Xiao L, Mao Y, Tong Z, Zhao Y, Hong H, Wang F. Radiation exposure triggers the malignancy of non‑small cell lung cancer cells through the activation of visfatin/Snail signaling. Oncol Rep 2021;45:1153-61. [PMID: 33432364 DOI: 10.3892/or.2021.7929] [Reference Citation Analysis]
6 Tang X, Sui X, Weng L, Liu Y. SNAIL1: Linking Tumor Metastasis to Immune Evasion. Front Immunol 2021;12:724200. [PMID: 34917071 DOI: 10.3389/fimmu.2021.724200] [Reference Citation Analysis]
7 Li Q, Yu D, Yu Z, Gao Q, Chen R, Zhou L, Wang R, Li Y, Qian Y, Zhao J, Rosell R, Tao M, Xie Y, Xu C. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis. Transl Lung Cancer Res 2021;10:936-54. [PMID: 33718034 DOI: 10.21037/tlcr-21-147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Page A, Ortega A, Alameda JP, Navarro M, Paramio JM, Saiz-Pardo M, Almeida EI, Hernández P, Fernández-Aceñero MJ, García-Fernández RA, Casanova ML. IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization. Comput Struct Biotechnol J 2019;17:251-62. [PMID: 30867890 DOI: 10.1016/j.csbj.2019.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Guinde J, Frankel D, Perrin S, Delecourt V, Lévy N, Barlesi F, Astoul P, Roll P, Kaspi E. Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation? Cells 2018;7:E78. [PMID: 30012957 DOI: 10.3390/cells7070078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Chao D, Hu G, Li Q. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24748. [PMID: 33607820 DOI: 10.1097/MD.0000000000024748] [Reference Citation Analysis]
11 Luo Q, Li B, Li G. Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis. Onco Targets Ther 2020;13:2771-81. [PMID: 32308412 DOI: 10.2147/OTT.S241816] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Cai FY, Yao XM, Jing M, Kong L, Liu JJ, Fu M, Liu XZ, Zhang L, He SY, Li XT, Ju RJ. Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. J Liposome Res 2021;31:113-29. [PMID: 32200703 DOI: 10.1080/08982104.2020.1745831] [Cited by in F6Publishing: 1] [Reference Citation Analysis]